Smith & Nephew bolsters repless Syncera program

Smith & Nephew buys a pair of software assets to bolster its Syncera repless sales business.

Smith & Nephew (NYSE:SNN) added a pair of software assets to its Syncera generic sales business, a so-called "repless" model for orthopedic devices.

S2 Interactive, Smith & Nephew

News Well, Mergers & Acquisitions, Repless (generic) sales, Software / IT

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zMqeva